These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2667681)

  • 21. The actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog.
    Corder R; Lowry PJ; Withrington PG
    Br J Pharmacol; 1987 Apr; 90(4):785-90. PubMed ID: 3580708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition by amlodipine of activity evoked in isolated human coronary arteries by endothelin, prostaglandin F2 alpha and depolarization.
    Godfraind T; Mennig D; Bravo G; Chalant C; Jaumin P
    Am J Cardiol; 1989 Nov; 64(17):58I-64I. PubMed ID: 2530886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of endothelin on human coronary arteries and localization of its binding sites.
    Chester AH; Dashwood MR; Clarke JG; Larkin SW; Davies GJ; Tadjkarimi S; Maseri A; Yacoub MH
    Am J Cardiol; 1989 Jun; 63(18):1395-8. PubMed ID: 2658527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits.
    Andersson D; Brunkwall J; Bergqvist D; Edvinsson L
    J Auton Nerv Syst; 1992 Mar; 37(3):215-22. PubMed ID: 1587998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists.
    Awane-Igata Y; Ikeda S; Watanabe T
    Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of endothelin as a coronary vasoconstrictor in the Langendorff-perfused rat heart.
    Fukuda K; Hori S; Kusuhara M; Satoh T; Kyotani S; Handa S; Nakamura Y; Oono H; Yamaguchi K
    Eur J Pharmacol; 1989 Jun; 165(2-3):301-4. PubMed ID: 2673800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characteristics of the canine cerebrovascular constriction produced by neuropeptide Y.
    Uneyama H; Tanaka Y; Iwata S; Ishiguro T; Nakayama K
    Biol Pharm Bull; 1995 Apr; 18(4):501-6. PubMed ID: 7655416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
    Andriantsitohaina R; Stoclet JC
    Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelium removal does not affect potentiation by neuropeptide Y in rabbit ear artery.
    Budai D; Vu HQ; Duckles SP
    Eur J Pharmacol; 1989 Sep; 168(1):97-100. PubMed ID: 2583236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin is a potent long-lasting vasoconstrictor in men.
    Clarke JG; Benjamin N; Larkin SW; Webb DJ; Davies GJ; Maseri A
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H2033-5. PubMed ID: 2690644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1.
    Kimura S; Kasuya Y; Sawamura T; Shinimi O; Sugita Y; Yanagisawa M; Goto K; Masaki T
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S5-7; discussion S18. PubMed ID: 2473327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adrenomedullary venous vasculature as a target for endothelins: comparison of the porcine and bovine central adrenomedullary veins.
    Bjerkås H; Lønning K; Helle KB
    Comp Biochem Physiol A Mol Integr Physiol; 1998 Jul; 120(3):439-46. PubMed ID: 9787829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y is a vasoconstrictor of human coronary arteries.
    Tseng CJ; Robertson D; Light RT; Atkinson JR; Robertson RM
    Am J Med Sci; 1988 Jul; 296(1):11-6. PubMed ID: 3407677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: blockade by D-myo-inositol-1,2,6-triphosphate.
    Edvinsson L; Adamsson M
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):466-72. PubMed ID: 1279294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
    Gradin KA; Li JY; Andersson O; Simonsen U
    J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct positive inotropic and vasoconstrictor effects of endothelin.
    Siegfried MR; Aoki N; Mulloy D; Lefer AM
    Heart Vessels; 1990; 5(3):146-51. PubMed ID: 2193909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of the biphasic responses to endothelin-3 in dog coronary arteries.
    Okamura T; Matsumoto T; Ikemoto F; Toda N
    Br J Pharmacol; 1992 Dec; 107(4):1037-41. PubMed ID: 1467826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of neuropeptide Y and calcitonin gene-related peptide on sheep coronary artery rings under oxygenated, hypoxic and simulated myocardial ischaemic conditions.
    Kwan YW; Wadsworth RM; Kane KA
    Br J Pharmacol; 1990 Apr; 99(4):774-8. PubMed ID: 2361172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of thiopental, pentobarbital, and ketamine on endothelin-induced constriction of porcine cerebral arteries.
    Taga K; Fukuda S; Nishimura N; Tsukui A; Morioka M; Shimoji K
    Anesthesiology; 1990 May; 72(5):939-41. PubMed ID: 2187378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
    Han C; Abel PW
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.